Biomarkers and Precision Ophthalmology focuses on tailoring diagnosis, prognosis, and treatment according to individual biological and clinical characteristics. The session explores molecular, imaging, genetic, and systemic biomarkers together with patient stratification, predictive modeling, treatment-response assessment, and precision approaches across ophthalmic disease.
Abstract Scope and Participation
Abstracts may investigate biomarker discovery, validation, precision diagnostics, treatment prediction, personalized therapy, patient stratification, and clinical translation. Ophthalmologists, researchers, molecular scientists, imaging specialists, bioinformaticians, clinicians, and professionals working in personalized medicine are encouraged to contribute.







Title : Lenadogene nolparvovec gene therapy in leber hereditary optic neuropathy
Magali Taiel, GenSight Biologics, France
Title : Stereotactic radiotherapy for wet age-related macular degeneration: year 4 results of a randomised, double-masked, sham-controlled trial
Tim Jackson, King’s College London, United Kingdom